Meta-analysis of the published results from 54 randomised controlled trials of adjuvant
chemotherapy in head and neck cancer suggests that chemotherapy might increase …

Abstract Background and purpose The Meta-Analysis of Chemotherapy in squamous cell
Head and Neck Cancer (MACH-NC) demonstrated that concomitant chemotherapy (CT) …

The survival rate is 40% for patients with advanced squamous cell carcinoma of the head
and neck whose tumors are completely resected and 20% for those with unresectable …

The antitumor activity of IFN-α is well established. However, the role of the plasmacytoid
dendritic cell (PDC), the major producer of IFN-α upon viral infection, in tumor biology is …

PURPOSE Using the technique of meta-analysis, we aim to illustrate the potential benefit, or
lack of it, in adding chemotherapy to locoregional definitive treatment in a prospective …

A multivariate analysis was carried out in 492 patients with metastatic neck disease from
squamous cell carcinoma to determine the influence of clinical and therapeutic factors on …

Purpose: A prospective randomized trial was conducted to compare chemoradiotherapy
against radiotherapy alone in the treatment of locoregionally advanced nasopharyngeal …

Background A phase III randomized comparison of radiotherapy alone versus combination
chemotherapy and concurrent continuous‐course radiotherapy was performed at the …

The multidisciplinary approach to treating squamous cell carcinoma of the head and neck is
complex and evolving. This article aims to review some recent developments in squamous …

BACKGROUND Nasopharyngeal carcinoma (NPC) is a radiosensitive tumor for which there
is a high local control rate after radical radiotherapy (RT). However, for patients with …